IL-36 cytokine expression and its relationship with p38 MAPK and NF-κB pathways in psoriasis vulgaris skin lesions

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 4, 2013, Pages 594-599

  He, Qi ^a   Chen, Hong Xiang ^a   Li, Wen ^a   Wu, Yan ^a   Chen, Shan Juan ^a   Yue, Qing ^a   Xiao, Min ^a   Li, Jia Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

interleukin 36; nuclear factor kappa B; p38 mitogen activated protein kinase; psoriasis vulgaris

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 36, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PSORIASIS; SIGNAL TRANSDUCTION; SKIN; YOUNG ADULT;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PSORIASIS; SIGNAL TRANSDUCTION; SKIN; YOUNG ADULT;

EID: 84881285699     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1164-1     Document Type: Article

References (25)

1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med, 2009,361(5):496-509
2. Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol, 2001,26(4):314-320
3. Hashimoto S, Matsumoto K, Gon Y, et al. p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells. Clin Exp Allergy, 2000,30(1):48-55
4. Holden NS, Catley MC, Cambridge LM, et al. ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. Eur J Biochem, 2004,271(4):785-791
5. Wuertz K, Vo N, Kletsas D, et al. Inflammatory and catabolic signalling in intervertebral discs: the roles of NF-κB and MAP kinases. Eur Cell Mater, 2012,23:103-119; discussion 119-120
6. Wang S, Uchi H, Hayashida S, et al. Differential expression of phosphorylated extracellular signal-regulated kinase 1/2, phosphorylated p38 mitogen-activated protein kinase and nuclear factor-kappaB p105/p50 in chronic inflammatory skin diseases. J Dermatol, 2009,36(10): 534-540
7. Towne J, Sims J. IL-36 in psoriasis. Curr Opin Pharmacol, 2012,12(4):486-490
8. Johnston A, Xing X, Guzman AM, et al. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol, 2011,186(4):2613-2622
9. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol, 2007,127(3):514-525
10. Nograles KE, Davidovici B, Krueger JG. New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg, 2010,29(1):3-9
11. Towne JE, Garka KE, Renshaw BR, et al. Interleukin(IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem, 2004,279(14): 13677-13688
12. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol, 2010,10(2):89-102
13. Blumberg H, Dinh H, Trueblood ES, et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med, 2007,204(11): 2603-2614
14. Blumberg H, Dinh H, Dean C Jr, et al. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol, 2010,185(7):4354-4362
15. Carrier Y, Ma HL, Ramon HE, et al. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol, 2011,131(12):2428-2437
16. Zhang P, Martin M, Michalek SM, et al. Role of mitogen- activated protein kinases and NF-kappaB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B. Infect Immun, 2005, 73(7):3990-3998
17. Albanesi C, Scarponi C, Giustizieri ML, et al. Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy, 2005,4(3):329-334
18. Bubici C, Papa S, Dean K, et al. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene, 2006,25(51):6731-6748
19. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE, 2006,2006(357):re13
20. Hayden MS, Ghosh S. Shared principles in NFkappaB signaling. Cell, 2008, 132(3):344-362
21. Xiao YQ, Malcolm K, Worthen GS, et al. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem, 2002,277(17): 14884-14893
22. Fecher LA, Amaravadi RK, Flaherty KT. The MAPK pathway in melanoma. Curr Opin Oncol, 2008,20(2): 183-189
23. Yu XJ, Li CY, Dai HY, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol, 2007,83(3): 413-418
24. Bell S, Degitz K, Quirling M, et al. Involvement of NF-kappaB signalling in skin physiology and disease. Cell Signal, 2003,15(1):1-7
25. Kaur J, Woodman RC, Kubes P. P38 MAPK: critical molecule in thrombin-induced NF-kappa B-dependent leukocyte recruitment. Am J Physiol Heart Circ Physiol, 2003,284(4):H1095-H1103